HENDERSON, Nev.--(BUSINESS WIRE)-- Zura Bio Limited (Nasdaq: ZURA) has announced the issuance of inducement awards to seven new employees, including Eric Hyllengren, the newly appointed Chief Financial Officer. On July 15, 2025, the company granted options to purchase up to 890,950 Class A Ordinary Shares, with 672,000 options awarded to Hyllengren. These awards were approved by the Compensation Committee and the Board, granted outside the 2023 Equity Incentive Plan, and are in alignment with Nasdaq Listing Rule 5635(c)(4). The options will vest incrementally, with one fourth vesting on the vesting commencement date and the remainder vesting in equal quarterly installments, contingent upon continuous service.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。